EEF1A2 and Parkinson disease: After exposure to the neurotoxin 1-methyl-4-phenylpyridinium (MPP+) to establish a cellular model of PD, the mRNA and protein expression of eEF1A2 increased in both undifferentiated and differentiated SH-SY5Y cells, with relatively greater in the differentiated cells.